DCF Advisers’s Lifecore Biomedical LFCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.58M Sell
424,500
-17,500
-4% -$121K 0.6% 44
2025
Q4
$3.62M Sell
442,000
-10,000
-2% -$74K 1.19% 31
2025
Q3
$3.33M Sell
452,000
-10,987
-2% -$83.1K 1.26% 29
2025
Q2
$3.76M Sell
462,987
-20,013
-4% -$135K 1.81% 20
2025
Q1
$3.4M Sell
483,000
-56,989
-11% -$354K 1.83% 20
2024
Q4
$4.01M Buy
539,989
+251,511
+87% +$1.61M 2.03% 18
2024
Q3
$1.42M Sell
288,478
-2,206
-0.8% -$11.5K 0.73% 39
2024
Q2
$1.49M Buy
290,684
+6,000
+2% +$35.5K 0.78% 37
2024
Q1
$1.51M Buy
284,684
+25,000
+10% +$179K 0.91% 31
2023
Q4
$1.61M Buy
259,684
+138,930
+115% +$965K 1.09% 29
2023
Q3
$911K Buy
120,754
+33,254
+38% +$304K 0.64% 45
2023
Q2
$846K Buy
+87,500
New +$534K 0.58% 43

Other funds holding LFCR